Zydus Lifesciences Limited — Bisacodyl Exporter Profile
Indian Pharmaceutical Exporter · #8 for Bisacodyl · $258.5K export value · DGFT Verified
Zydus Lifesciences Limited is the #8 Indian exporter of Bisacodyl with $258.5K in export value and 35 verified shipments. Zydus Lifesciences Limited holds a 3.0% market share in Bisacodyl exports across 4 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Bisacodyl Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Bisacodyl?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $248.1K | 25 | 96.0% |
| TRINIDAD & TOBAGO | $9.3K | 7 | 3.6% |
| BAHAMAS | $625 | 1 | 0.2% |
| GUYANA | $519 | 2 | 0.2% |
Zydus Lifesciences Limited exports Bisacodyl to 4 countries. The largest destination is SRI LANKA accounting for 96.0% of Zydus Lifesciences Limited's Bisacodyl shipments, followed by TRINIDAD & TOBAGO (3.6%) and BAHAMAS (0.2%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bisacodyl from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HEMAS PHARMACEUTICALS (PVT) LTD | SRI LANKA | $122.6K | 15 |
| STATE PHARMACEUTICALS | SRI LANKA | $59.5K | 3 |
| HEMAS PHARMACEUTICALS PVT LTD | SRI LANKA | $42.9K | 4 |
| HEMAS PHARMACEUTICALS (PRIVATE) LIMITED | SRI LANKA | $23.0K | 3 |
| SUPERIOR PHARMA LIMITED | TRINIDAD & TOBAGO | $9.3K | 7 |
| BAHAMAS MEDICAL & SURGICAL SUPPLIES | BAHAMAS | $625 | 1 |
| NEW GPC INC | GUYANA | $519 | 2 |
Zydus Lifesciences Limited supplies Bisacodyl to 7 buyers globally. The largest buyer is HEMAS PHARMACEUTICALS (PVT) LTD (SRI LANKA), followed by STATE PHARMACEUTICALS (SRI LANKA) and HEMAS PHARMACEUTICALS PVT LTD (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bisacodyl Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $6.4M worth of Bisacodyl through 1,294 shipments from 240 suppliers to 108 countries, serving 415 buyers globally. Zydus Lifesciences Limited contributes $258.5K to this total, accounting for 3.0% of India's Bisacodyl exports. Zydus Lifesciences Limited ships Bisacodyl to 4 countries through 7 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Bisacodyl Exports?
Zydus Lifesciences Limited's average Bisacodyl shipment value is $7.4K per consignment, based on 35 shipments totaling $258.5K. The largest destination is SRI LANKA (96.0% of Zydus Lifesciences Limited's Bisacodyl exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Bisacodyl Exporters?
Zydus Lifesciences Limited ranks #8 among 240 Indian Bisacodyl exporters with a 3.0% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($2.0M), IND SWIFT LIMITED ($760.7K), BLISS GVS PHARMA LIMITED ($712.9K). Zydus Lifesciences Limited processed 35 shipments to 4 destination countries.
What Bisacodyl Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ZYCOLAX FORTE 10MG TABS (BISACODYL DELAY | $54.1K | 2 |
| ZYCOLAX 10 SUPPOS 10MG 5S (BISACODYL SUP | $22.8K | 3 |
| ZYCOLAX SUPP'S(I) 5MG 5'S (BISACODYL SUPPOSITORIES IP 5MG) 1X5 UNDER LUT NO.AD240324091585Z dated 19.03.2024 valid up to | $21.6K | 1 |
| ZYCOLAX 10MG SUPPOSITORIES BISACODYL SUPPOSITORIES IP 10MG 1X5 UNDER LUT NO AD240322015696A DT 17 03 2022 VALID UP TO | $19.4K | 2 |
| ZYCOLAX SUPP'S 10MG 5'S (BISACODYL SUPPOSITORIES IP 10MG) 1X5 UNDER LUT NO.AD240324091585Z dated 19.03.2024 valid up to | $18.1K | 1 |
| ZYCOLAX SUPP'S(I) 5MG 5'S (BISACODYL SUP | $12.0K | 4 |
| ZYCOLAX 5MG TABS (BISACODYL USP 5MG) 10X | $11.8K | 2 |
| ZYCOLAX SUPP'S(I) 5MG 5'S(BISACODYL SUPP | $11.6K | 1 |
| ZYCOLAX 5MG TABS (BISACODYL USP 5MG) 10X10 UNDER LUT NO.AD300323000664T DT.16.03.2023 VALID UP TO DT.31.03.2024NOS | $11.1K | 1 |
| ZYCOLAX 10 SUPPOSITORIES (BISACODYL SUPPOSITORIES IP 10MG) 3X5 SHIPMENT UNDER LUT NO. AD240324091585Z dated 19.03.2024 v | $10.7K | 1 |
Zydus Lifesciences Limited exports 24 distinct Bisacodyl formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ZYCOLAX FORTE 10MG TABS (BISACODYL DELAY with 2 shipments worth $54.1K.
How Does Zydus Lifesciences Limited Compare to Nearest Bisacodyl Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | DR.REDDY'S LABORATORIES LIMITED | $291.9K | 19 | 1 | $15.4K |
| 7 | DR REDDY S LABORATORIES LIMITED | $282.8K | 10 | 1 | $28.3K |
| 8 | ZYDUS LIFESCIENCES LIMITED ★ | $258.5K | 35 | 4 | $7.4K |
| 9 | ARAVIS PHARMACEUTICALS | $230.9K | 10 | 1 | $23.1K |
| 10 | ADCOCK INGRAM LIMITED | $214.6K | 23 | 1 | $9.3K |
Zydus Lifesciences Limited ranks #8 among 240 Indian Bisacodyl exporters. Average shipment value of $7.4K compared to the market average of $26.5K. The closest competitors by value are DR.REDDY'S LABORATORIES LIMITED and DR REDDY S LABORATORIES LIMITED.
Which Indian Ports Ship Bisacodyl Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 168 | 13.0% |
| NHAVA SHEVA SEA (INNSA1) | 159 | 12.3% |
| SAHAR AIR | 152 | 11.7% |
| JNPT/ NHAVA SHEVA SEA | 74 | 5.7% |
| HYDERABAD ICD | 60 | 4.6% |
| JNPT | 58 | 4.5% |
| Bombay Air | 42 | 3.2% |
| AHEMDABAD ICD | 32 | 2.5% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Bisacodyl Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Bisacodyl, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bisacodyl — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bisacodyl shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 35 individual customs records matching Zydus Lifesciences Limited exporting Bisacodyl, covering 24 formulations to 4 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 415+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bisacodyl Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Bisacodyl exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Bisacodyl Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bisacodyl. For current shipment-level data, contact TransData Nexus.